These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 16214789)

  • 1. Use of porous aluminosilicate pellets for drug delivery.
    Byrne RS; Deasy PB
    J Microencapsul; 2005 Jun; 22(4):423-37. PubMed ID: 16214789
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Use of commercial porous ceramic particles for sustained drug delivery.
    Byrne RS; Deasy PB
    Int J Pharm; 2002 Oct; 246(1-2):61-73. PubMed ID: 12270609
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Use of coated microtubular halloysite for the sustained release of diltiazem hydrochloride and propranolol hydrochloride.
    Levis SR; Deasy PB
    Int J Pharm; 2003 Mar; 253(1-2):145-57. PubMed ID: 12593945
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In vitro behavior of dronedarone hydrochloride loaded pellets using vacuum impregnation technique.
    Gretić M; Štanfel M; Barbarić J; Rimac N; Matijašić G
    Eur J Pharm Biopharm; 2021 May; 162():70-81. PubMed ID: 33727144
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Formulation of rate-modulating pellets for the release of ibuprofen: an extrusion-spheronization process.
    Lutchman D; Dangor CM; Perumal D
    J Microencapsul; 2005 Sep; 22(6):643-59. PubMed ID: 16401580
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In vitro and in vivo evaluations of ketoprofen extended release pellets prepared using powder layering technique in a rotary centrifugal granulator.
    Pai R; Kohli K; Jain G; Srivastava B
    Arch Pharm Res; 2011 Jul; 34(7):1135-42. PubMed ID: 21811920
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The influence of liquid binder on the liquid mobility and preparation of spherical granules by the process of extrusion/spheronization.
    Boutell S; Newton JM; Bloor JR; Hayes G
    Int J Pharm; 2002 May; 238(1-2):61-76. PubMed ID: 11996811
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Eudragit NE40-drug mixed coating system for controlling drug release of core pellets.
    Rahman NU; Yuen KH
    Drug Dev Ind Pharm; 2005 May; 31(4-5):339-47. PubMed ID: 16093199
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Use of extrusion aids for successful production of Kollidon
    Loka NC; Saripella KK; Pinto CA; Neau SH
    Drug Dev Ind Pharm; 2018 Apr; 44(4):632-642. PubMed ID: 29183166
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Properties of drug-containing spherical pellets produced by a hot-melt extrusion and spheronization process.
    Young CR; Koleng JJ; McGinity JW
    J Microencapsul; 2003; 20(5):613-25. PubMed ID: 12909545
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hydrocolloid carriers with filler inclusion for diltiazem hydrochloride release.
    Gal A; Nussinovitch A
    J Pharm Sci; 2007 Jan; 96(1):168-78. PubMed ID: 17031844
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lipids bearing extruded-spheronized pellets for extended release of poorly soluble antiemetic agent-Meclizine HCl.
    Qazi F; Shoaib MH; Yousuf RI; Nasiri MI; Ahmed K; Ahmad M
    Lipids Health Dis; 2017 Apr; 16(1):75. PubMed ID: 28403892
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A ceramic drug delivery vehicle for oral administration of highly potent opioids.
    Forsgren J; Jämstorp E; Bredenberg S; Engqvist H; Strømme M
    J Pharm Sci; 2010 Jan; 99(1):219-26. PubMed ID: 19492338
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Porous pellets as drug delivery system.
    Cosijns A; Nizet D; Nikolakakis I; Vervaet C; De Beer T; Siepmann F; Siepmann J; Evrard B; Remon JP
    Drug Dev Ind Pharm; 2009 Jun; 35(6):655-62. PubMed ID: 19259877
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Properties of melt extruded enteric matrix pellets.
    Schilling SU; Shah NH; Waseem Malick A; McGinity JW
    Eur J Pharm Biopharm; 2010 Feb; 74(2):352-61. PubMed ID: 19782133
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Development of a novel osmotically driven drug delivery system for weakly basic drugs.
    Guthmann C; Lipp R; Wagner T; Kranz H
    Eur J Pharm Biopharm; 2008 Jun; 69(2):667-74. PubMed ID: 18226884
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Development and in vitro evaluation of ketoprofen extended release pellets using powder layering technique in a rotary centrifugal granulator.
    Pai R; Pai A; Srivastava B; Kohli K
    Comb Chem High Throughput Screen; 2011 Feb; 14(2):138-45. PubMed ID: 21118082
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Development and in vitro-in vivo evaluation of a multiparticulate sustained release formulation of diltiazem.
    Li SP; Felt RG; Di Paolo LC; Huang MY; Williams RO
    Pharm Res; 1995 Sep; 12(9):1338-42. PubMed ID: 8570532
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Wax-based sustained release matrix pellets prepared by a novel freeze pelletization technique II. In vitro drug release studies and release mechanisms.
    Cheboyina S; Wyandt CM
    Int J Pharm; 2008 Jul; 359(1-2):167-73. PubMed ID: 18495391
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Bulk Freeze-Drying Milling: a Versatile Method of Developing Highly Porous Cushioning Excipients for Compacted Multiple-Unit Pellet Systems (MUPS).
    Siow CRS; Heng PWS; Chan LW
    AAPS PharmSciTech; 2018 Feb; 19(2):845-857. PubMed ID: 29019116
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.